SINGAPORE--(BUSINESS WIRE)--BW LPG Limited (“BW LPG”, the “Company”, OSE ticker code: “BWLPG.OL”, NYSE ticker code: “BWLP”), the owner and operator of the world's largest fleet of Very Large Gas Carriers (VLGCs), announces today that it will release its Q3 2025 Financial Report at approximately 07:00hrs CET/ 01:00hrs EST/ 14:00hrs SGT on 2 December 2025. In connection with this release, BW LPG will hold an Earnings Presentation with Kristian Sørensen (CEO) and Samantha Xu (CFO). The details are.

image for news BW LPG Limited – Q3 2025 Financial Report Release and Earnings Presentation on 2 December 2025

Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer — Neutral

ZYME   GlobeNewsWire — November 18, 2025

VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics today announced the appointment of Scott Platshon as Acting Chief Investment Officer.

image for news Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer

Allegiant Adds 30 New Nonstop Routes, Entering Four New Markets — Neutral

ALGT   PRNewsWire — November 18, 2025

The airline is launching service to La Crosse, Wis., Trenton, N.J.

image for news Allegiant Adds 30 New Nonstop Routes, Entering Four New Markets

Creates a global coatings leader with $17 billion in revenue and an enterprise value of $25 billion Significant value creation with approximately $600 million in cost synergies supporting strategic and capital allocation priorities Combines highly complementary portfolios across end markets, driving stronger revenue growth, enhanced profitability and increased value for customers Expands geographic reach, brings together world-class technology and innovation platforms and offers a full spectrum of solutions to deliver exceptional value to customers Highly attractive financial profile featuring strong EBITDA margins and robust cash flow generation One ‑ tier Board to be led by current Axalta Chair Rakesh Sachdev …

image for news AkzoNobel and Axalta to Combine in All-Stock Merger of Equals, Creating a Premier Global Coatings Company

VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME) a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced a novel strategic initiative focused on optimizing future cash flows from Ziihera® (zanidatamab-hrii), other licensed products and other healthcare assets. Together with the ability to leverage existing and future R&D partnerships and collaborations through internal innovation, this strategy seeks to optimize a long-term source of growing revenue streams with carefully managed R&D investments to establish a durable, profitable operating structure.

image for news Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets

S&P Global Publishes Findings on Unlocking Africa's Economic Potential — Neutral

SPGI   PRNewsWire — November 18, 2025

Look Forward: Unlocking Africa brings together S&P Global research on the continent's economic outlook Report highlights how renewable energy, sustainable and blended finance, capital market development, and infrastructure investment are shaping Africa's future JOHANNESBURG , Nov. 18, 2025 /PRNewswire/ -- Africa's abundant natural resources, young population and expanding middle class are set to redefine the continent's role in global economic growth, sustainable development and the energy transition, S&P Global said in its latest Look Forward Journal. Look Forward: Unlocking Africa brings together S&P Global research on the continent's economic outlook, highlighting how renewable energy, sustainable and blended finance, capital market …

image for news S&P Global Publishes Findings on Unlocking Africa's Economic Potential

Freshworks: Underappreciated Growth And Cash Flow At A Discount Price — Positive

FRSH   Seeking Alpha — November 18, 2025

Freshworks Inc. delivered a strong Q3, beating revenue and EPS estimates, and raised full-year guidance, reinforcing its position in my portfolio. FRSH is successfully moving upstream, winning larger contracts, and leveraging AI-driven products, like Freddy Copilot, to drive customer spend and retention. Despite high stock-based compensation impacting GAAP profitability, SBC is declining, and strong cash flows support potential new share buybacks.

image for news Freshworks: Underappreciated Growth And Cash Flow At A Discount Price

OPEC Secretary General hits back at global oil surplus reports — Neutral

BNO  DBO  GUSH  IEO  OIH  OIL  PXJ  UCO  USO  XOP   CNBC International TV — November 18, 2025

OPEC's Secretary General pushes back against reports of a looming global oil surplus in 2026 in an interview with CNBC's Dan Murphy.

image for news OPEC Secretary General hits back at global oil surplus reports

Honda Motor said it will begin gradually resuming normal operations at its North American vehicle assembly plants from Monday, a sign that production disruptions from a shortage of Nexperia chips are easing.

image for news Honda to resume regular output at N. America plants after chip supply disruptions

SAN DIEGO , Nov. 18, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Skye Bioscience, Inc. (NYSE: FCX) securities between November 4, 2024 and October 3, 2025. Skye is a clinical stage biopharmaceutical company that focuses on developing molecules that modulate G protein-coupled receptors ("GPCRs") to treat obesity, overweight, and metabolic diseases.

image for news Investor Alert: Robbins LLP Informs Investors of the Skye Bioscience, Inc. Class Action

MoonLake: Ignore The Panic, Catch The Upside — Positive

MLTX   Seeking Alpha — November 18, 2025

MoonLake Immunotherapeutics is rated Buy, with sonelokimab having multiple dermatology and rheumatology indications. MLTX's VELA-1 trial succeeded, and VELA-2's statistical miss was due to elevated placebo response, not drug failure; combined analysis remains highly significant. Regulatory precedent, a strong financial runway into 2027, and multiple upcoming catalysts support a compelling asymmetric risk-reward profile for MLTX.

image for news MoonLake: Ignore The Panic, Catch The Upside

Beyond by RS2 Becomes a Principal Issuing Member of Visa — Neutral

V   Business Wire — November 18, 2025

FRANKFURT, Germany--(BUSINESS WIRE)-- #BINSponsoring--Beyond by RS2, the innovation brand of RS2 Financial Services GmbH, has become a Principal Issuing Member of Visa in Europe – allowing the company to directly issue Visa cards and to launch and manage payment card programs. With this milestone, Beyond by RS2 strengthens its position as an end-to-end payment partner, combining issuing, acquiring, and processing services within a regulated framework to support banks, fintechs, corporates, and merchants in deve.

image for news Beyond by RS2 Becomes a Principal Issuing Member of Visa

Soluna Holdings: Bridging Renewable Energy And AI Compute Demand — Positive

SLNH   Seeking Alpha — November 18, 2025

Soluna Holdings is rated a BUY, leveraging surplus renewable energy for modular data centers and pivoting toward AI and high-performance compute clients. SLNH has maintained gross margins around 25% and secured $35M in new funding for Texas data center expansions. The company is diversifying away from crypto mining, focusing on AI-driven data center hosting, with Project Dorothy 2 and Project Kati as key growth catalysts.

image for news Soluna Holdings: Bridging Renewable Energy And AI Compute Demand

DULUTH, Ga.--(BUSINESS WIRE)--The road to financial recovery may be long, but middle-income families are proving resilient as they adapt to higher costs and redefine their financial goals, according to a new special report from Primerica, Inc. (NYSE: PRI), a leading provider of financial products and services to middle-income families. Titled “The Inflation Hangover: Middle-Income Americans Build Resilience on the Long Road to Recovery,” the report offers an in-depth look at how middle-income h.

image for news Special Report Shows How Middle-Income Families Are Navigating the ‘Inflation Hangover'

Paladin Energy Ltd (PALAF) Shareholder/Analyst Call Transcript — Neutral

PALAF  PDN   Seeking Alpha — November 17, 2025

Paladin Energy Ltd (OTCQX:PALAF) Shareholder/Analyst Call November 17, 2025 8:00 PM EST Company Participants Mark Lawrenson Paul Hemburrow - MD, CEO & Director Anne Templeman-Jones Michele Buchignani Alexander Rybak - Chief Commercial Officer Presentation Mark Lawrenson Ladies and gentlemen, we can start the meeting. My name is Cliff Lawrenson, and I'm the Chair of the Board of Paladin Energy.

image for news Paladin Energy Ltd (PALAF) Shareholder/Analyst Call Transcript

Meta: The AI Roadmap Remains Underappreciated — Positive

META   Seeking Alpha — November 17, 2025

Meta's advertising business remains incredibly strong, with improving engagement metrics and ad prices along with accelerating adoption of AI tools like Advantage+. The firm is currently in the middle of a very heavy CapEx cycle that will pressure margins over the near term but will likely improve sales in the future. The pros appear to vastly outweigh the cons for Meta, and my DCF model indicates the stock is significantly undervalued, especially following the recent sell-off.

image for news Meta: The AI Roadmap Remains Underappreciated

Perma-Pipe International Holdings is a specialized pipe manufacturer, operating primarily in the Middle East and North America. PPIH is poised to benefit from increased capital expenditures in the Middle East, supporting its expansion and revenue growth. Company backlog signals significant revenue growth ahead, as shown by the attractive Book-to-Bill ratio.

image for news Perma-Pipe: AI, HPC, And Middle East Tailwinds Coupled With An Attractive Valuation

FOSTER CITY, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California-based late-stage clinical biopharmaceutical company, today announced the following update regarding changes to the Company's board of directors (“Board”) and composition of committees.

image for news Apollomics Announces Changes to its Board of Directors and Composition of Committees

HAWTHORNE, Calif.--(BUSINESS WIRE)--OSI Systems, Inc. (NASDAQ: OSIS) (the “Company” or “OSI”) today announced the pricing of its offering of $500 million aggregate principal amount of 0.50% convertible senior notes due 2031 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering size of $.

image for news OSI Systems, Inc. Prices Upsized $500 Million Convertible Senior Notes Offering

HIVE Digital Technologies Ltd. (HIVE:CA) Q2 2026 Earnings Call Transcript — Neutral

HIVE   Seeking Alpha — November 17, 2025

HIVE Digital Technologies Ltd. ( HIVE:CA ) Q2 2026 Earnings Call November 17, 2025 8:00 AM EST Company Participants Nathan Fast Frank Holmes - Executive Chairman Aydin Kilic - President & CEO Darcy Daubaras - Chief Financial Officer Conference Call Participants Darren Aftahi - ROTH Capital Partners, LLC, Research Division Mike Grondahl - Northland Capital Markets, Research Division Bill Papanastasiou Christopher Brendler - Rosenblatt Securities Inc., Research Division Fedor Shabalin - B.

image for news HIVE Digital Technologies Ltd. (HIVE:CA) Q2 2026 Earnings Call Transcript